FDA inspection
University of Vermont & State Agricultural College IRB: FDA inspection ending Sep 26, 2025
FDA inspection 1284600 · Burlington, VT
Key facts
| Inspection ID | 1284600 |
|---|---|
| Firm | University of Vermont & State Agricultural College IRB |
| FEI number | 1283215 |
| Address | 85 S Prospect St 213 Waterman Building |
| City | Burlington |
| State | VT |
| ZIP | 05405-1704 |
| Fiscal year | 2025 |
| Inspection end date | Sep 26, 2025 |
| Project area | Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Bioresearch Monitoring: Human Drugs|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices|Human Cellular, Tissue, and Gene Therapies|Product Evaluation: Medical Devices |
| Product type | Biologics, Devices, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data